NCT03659409

Brief Summary

This study evaluates the impact of mindfulness-based interventions on psycho-social and physiological well-being among stroke survivors and their family caregivers. This study will employ a treatment wait-list cross-over design, with half the participants randomized to receive the intervention first (treatment group), while the other half receives the interventions 2 months following the end of the treatment phase (wait-list group).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started May 2016

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 12, 2016

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2018

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 6, 2018

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2018

Completed
Last Updated

March 19, 2020

Status Verified

March 1, 2020

Enrollment Period

2.6 years

First QC Date

May 13, 2018

Last Update Submit

March 17, 2020

Conditions

Keywords

MindfulnessStroke SurvivorsCaregivers

Outcome Measures

Primary Outcomes (5)

  • Cohen Perceived Stress Scale

    A 10-item measure evaluating the perception of stress.

    Past 1 Month

  • Centre for Epidemiologic Studies Depression Scale (CES-D)

    A 20-item measure for epidemiological research on depression.

    Past 1 Week

  • Stroke Specific Quality of Life Scale (SS-QOL)

    A 49-item self-report questionnaire designed to measure the heath related quality of life specific to stroke survivors across 12 domains.

    Past 1 Month

  • Stroke Impact Scale (SIS)

    A 64-item questionnaire that assesses across 8 domains

    1 week

  • Short-Form-36 (SF-36)

    A 36-item self-report survey of health, including physical and mental health. Higher scaled scores reflect better quality of health.

    A range from the past 4 to 52 weeks

Secondary Outcomes (3)

  • Zarit Burden Interview

    Past 1 Month

  • Five Facet Mindfulness Questionnaire

    Past 1 Month

  • Big Five Personality Inventory

    Past 1 Month

Other Outcomes (1)

  • Mental Fatigue Scale (MFS)

    1 Month

Study Arms (2)

Mindfulness Based Intervention

EXPERIMENTAL

4 weekly 2-hour sessions. Participants will be introduced, taught and guided in practice of mindfulness-based interventions that are focused on their (1) breath, (2) senses, (3) body and bodily movements, (4) feelings of empathy and compassion.

Behavioral: Mindfulness-Based Intervention

Treatment Waitlist Group

OTHER

Participants will receive no intervention, except for a baseline follow-up at the start and again at the end of the first phase. 2 months after the end of the first intervention phase, participants in this group will receive the same mindfulness-based intervention for 4 weeks.

Behavioral: Waitlist - Mindfulness-Based Intervention

Interventions

4 weekly 2-hour sessions. Participants will be introduced, taught and guided in practice of mindfulness-based interventions that are focused on their (1) breath, (2) senses, (3) body and bodily movements, (4) feelings of empathy and compassion.

Mindfulness Based Intervention

Participants in this group will only receive the Mindfulness-Based Intervention 3-months after they have started the study and baseline measurements. While participants in the Intervention Arm are receiving the treatment, this group will receive No intervention for the first four weeks and will continue as treatment as usual until it is their turn to receive the Intervention.

Treatment Waitlist Group

Eligibility Criteria

Age21 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Stroke Survivors
  • Family Caregivers
  • Able to speak and understand English Fluently
  • Comprehends and provides consent independently

You may not qualify if:

  • Cognitively impaired individuals with a MMSE Score of less than 20, MoCA score of less than 23
  • Depression and Anxiety Stress Scale Scores, DASS, Depression \>7, Anxiety \>8, and Stress \>13

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore General Hospital

Singapore, 169608, Singapore

Location

MeSH Terms

Conditions

StrokeAnxiety DisordersDepression

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMental DisordersBehavioral SymptomsBehavior

Study Officials

  • Kinjal Doshi, PhD

    Singapore General Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Participants are randomized to receive either the intervention or treatment as usual. The intervention is for 4 weeks, and 3 months from the start of the intervention, participants who were assigned to the treatment as usual group will receive the same intervention.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 13, 2018

First Posted

September 6, 2018

Study Start

May 12, 2016

Primary Completion

December 31, 2018

Study Completion

December 31, 2018

Last Updated

March 19, 2020

Record last verified: 2020-03

Locations